Skip to Content

Guggenheim SMid Cap Value A SEVAX Fund Analysis

| Analyst rating as of

Morningstar’s Analysis SEVAX

Will SEVAX outperform in future?

Get our overall rating based on a fundamental assessment of the pillars below.

A strong team, but high fees lessen its appeal.



Guggenheim SMid Cap Value’s experienced team and sensible quant model do not overcome indistinct fundamental research and elevated fees; it earns a Morningstar Analyst Rating of Neutral.

Unlock our full analysis with Morningstar Investor